Merck & Co., Inc. (LON:0QAH)
110.05
+0.46 (0.42%)
At close: Jan 30, 2026
Merck & Co. Market Cap
Merck & Co. has a market cap or net worth of 199.5 billion as of January 30, 2026. Its market cap has decreased by -3.58% in one year.
Market Cap
199.50B
Enterprise Value
216.42B
Revenue
47.79B
Ranking
n/a
PE Ratio
14.09
Stock Price
110.05
Market Cap Chart
Since January 2, 1968, Merck & Co.'s market cap has increased from 3.01B to 199.50B, an increase of 6,537.19%. That is a compound annual growth rate of 7.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 199.50B | 2.77% |
| Dec 31, 2025 | 194.11B | -3.43% |
| Dec 31, 2024 | 201.01B | -7.32% |
| Dec 29, 2023 | 216.89B | -7.10% |
| Dec 30, 2022 | 233.47B | 63.30% |
| Dec 31, 2021 | 142.97B | -5.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.92B |
| GSK plc | 75.29B |
| Haleon | 33.75B |
| Smith & Nephew | 10.55B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.11B |
| HUTCHMED (China) | 1.89B |